Don't Use Delafloxacin to Treat Most Skin Infections

November 2017

Delafloxacin (Baxdela, baks-DEH-lah) is a new quinolone antibiotic.

Think of it as similar to levofloxacin, but so far it's only approved to treat skin infections.

And lab data suggest delafloxacin may have better methicillin-resistant Staph aureus (MRSA) coverage than other quinolones.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Blood Products Ask Jehovah's Witness Patients if They Will Accept Blood-Derived Products
Nephrology Help Put Risk of Contrast-Associated Acute Kidney Injury in Perspective
New Drugs Don't Use Delafloxacin to Treat Most Skin Infections
Gastroenterology Don't Assume Instructions to Swallow Inhaled Steroids Are an Error
Kidney Disease Think About Gabapentin for Severe Itching Due to Chronic Kidney Disease
Antiplatelets Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent
Interactions Schedule All Oral Meds Apart From Potassium Binders
New Drugs Don't Expect the New Gout Med Duzallo to Be on Your Formulary
Pregnancy Promote Safe Opioid Use in Pregnant Women
Practice Explain When Study Results Are Clinically Meaningful to Patients
Dosage Forms Watch for Dosing Differences With the New Spironolactone Suspension CaroSpir